MedTrace Logo

Advanced Cutaneous Evaluator (ACE): Estimation of Clinical and Economic Impact

NCT07275385 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 73

Last updated 2025-12-10

No results posted yet for this study

Summary

ACE is a clinical decision support system for selecting appropriate products for the local treatment of chronic wounds. It was designed with a user-centered approach, and its usability and feasibility have been previously validated in pilot studies with nurses. This protocol will allow for the clinical validation of the software in 18 primary care centers, including the quantification of the clinical and economic effects of using the tool over 9 months. It is a mixed-methods design that includes a randomized controlled trial in which nursing staff incorporate the use of ACE into their routine clinical practice to support their decision-making process for chronic wound treatment. It also includes a usability evaluation throughout the study.

Conditions

  • Wounds and Injuries
  • Wound Complication

Interventions

DEVICE

Advanced Cutaneous Evaluator (ACE)

Nursing staff include the use of ACE in their routine clinical practice to support their chronic wound treatment decision-making process.

OTHER

Control (non-ACE)

Professionals in the non-ACE group will carry out their usual clinical practice of chronic wound care.

Sponsors & Collaborators

  • Fundacin Biomedica Galicia Sur

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-03-26
Primary Completion
2025-10-23
Completion
2025-11-06

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07275385 on ClinicalTrials.gov